Newer Anticonvulsant Drugs in Neuropathic Pain and Bipolar Disorder

References

• Rockliff B W, Davis E H. Controlled sequential trials of carbamazepine in trigeminal neuralgia. Arch Neurol 1966; 15: 129–36
   PubMed Web of Science ®Google Scholar
• Graham J G, Zilkha K J. Treatment of trigeminal neuralgia with carbamazepine: a follow-up study. Br Med J 1966; 5481: 210–1
   Google Scholar
• Kienast H W, Boshes L D. Clinical trials of carbamazepine in suppressing pain. Headache 1968; 8: 1–5
   Google Scholar
• Adornato D C, Jr., Dohn D F. Tegretol in the treatment of trigeminal neuralgia in thirty patients. Cleve Clin Q 1969; 36: 17–22
   Google Scholar
• Davis E H. Clinical trials of tegretol in trigeminal neuralgia. Headache 1969; 9: 77–82
   PubMedGoogle Scholar
• Lloyd-Smith D L, Sachdev K K. A long-term low-dosage study of carbamazepine in trigeminal neuralgia. Headache 1969; 9: 64–72
   Google Scholar
• Nicol C F. A four year double-blind study of tegretol in facial pain. Headache 1969; 9: 54–7
   PubMedGoogle Scholar
• Rice A S, Maton S. Gabapentin in postherpetic neuralgia: a randomized, double blind, placebo controlled study. Pain 2001; 94: 215–24
   PubMed Web of Science ®Google Scholar
• Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 1998; 280: 1837–42
   PubMed Web of Science ®Google Scholar
• Backonja M, Beydoun A, Edwards K R, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 1998; 280: 1831–6
   PubMed Web of Science ®Google Scholar
• Backonja M M. Gabapentin monotherapy for the symptomatic treatment of painful neuropathy: a multicenter, double-blind, placebo-controlled trial in patients with diabetes mellitus. Epilepsia 1999; 40(Suppl 6)S57–9, discussion S73–4
   Google Scholar
• Morello C M, Leckband S G, Stoner C P, Moorhouse D F, Sahagian G A. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch Intern Med 1999; 159: 1931–7
   PubMed Web of Science ®Google Scholar
• Wiffen P, Collins S, McQuay H, Carroll D, Jadad A, Moore A. Anticonvulsant drugs for acute and chronic pain. Cochrane Database Syst Rev 2000; CD001133
   Google Scholar
• Martin C, Martin A, Rud C, Valli M. Comparative study of sodium valproate and ketoprofen in the treatment of postoperative pain. Ann Fr Anesth Reanim 1988; 7: 387–92
   PubMedGoogle Scholar
• De Leon O A. Antiepileptic drugs for the acute and maintenance treatment of bipolar disorder. Harv Rev Psychiatry 2001; 9: 209–22
   PubMed Web of Science ®Google Scholar
• Ghaemi S N, Gaughan S. Novel anticonvulsants: a new generation of mood stabilizers?. Harv Rev Psychiatry 2000; 8: 1–7
   Google Scholar
• Letterman L, Markowitz J S. Gabapentin: a review of published experience in the treatment of bipolar disorder and other psychiatric conditions. Pharmacotherapy 1999; 19: 565–72
   PubMed Web of Science ®Google Scholar
• Maidment I D. Gabapentin treatment for bipolar disorders. Ann Pharmacother 2001; 35: 1264–9
   Google Scholar
• Ferrier I N. Lamotrigine and gabapentin. Alternative in the treatment of bipolar disorder. Neuropsychobiology 1998; 38: 192–7
   Google Scholar
• U.S. Preventative Services Task Force Staff. The Guide to Clinical Preventative Services: Report of the United States Preventive Services Task Force (2nd ed). Williams & Wilkins, Philadelphia 1996; 861–62
   Google Scholar
• Carta M G, Hardoy M C, Dessi I, Hardoy M J, Carpiniello B. Adjunctive gabapentin in patients with intellectual disability and bipolar spectrum disorders. J Intellect Disabil Res 2001; 45: 139–45
   Google Scholar
• Vieta E, Martinez-Aran A, Nieto E, et al. Adjunctive gabapentin treatment of bipolar disorder. Eur Psychiatry 2000; 15: 433–7
   PubMed Web of Science ®Google Scholar
• McElroy S L, Soutullo C A, Keck P E, Jr., Kmetz G F. A pilot trial of adjunctive gabapentin in the treatment of bipolar disorder. Ann Clin Psychiatry 1997; 9: 99–103
   PubMedGoogle Scholar
• Pande A C, Crockatt J G, Janney C A, Werth J L, Tsaroucha G. Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group. Bipolar Disord 2000; 2: 249–55
   PubMed Web of Science ®Google Scholar
• Schaffer C B, Schaffer L C. Open maintenance treatment of bipolar disorder spectrum patients who responded to gabapentin augmentation in the acute phase of treatment. J Affect Disord 1999; 55: 237–40
   PubMed Web of Science ®Google Scholar
• Young L T, Robb J C, Patelis-Siotis I, MacDonald C, Joffe R T. Acute treatment of bipolar depression with gabapentin. Biol Psychiatry 1997; 42: 851–3
   Google Scholar
• Young L T, Robb J C, Hasey G M, et al. Gabapentin as an adjunctive treatment in bipolar disorder. J Affect Disord 1999; 55: 73–7
   PubMed Web of Science ®Google Scholar
• Sokolski K N, Green C, Maris D E, DeMet E M. Gabapentin as an adjunct to standard mood stabilizers in outpatients with mixed bipolar symptomatology. Ann Clin Psychiatry 1999; 11: 217–22
   PubMedGoogle Scholar
• Perugi G, Toni C, Ruffolo G, Sartini S, Simonini E, Akiskal H. Clinical experience using adjunctive gabapentin in treatment-resistant bipolar mixed states. Pharmacopsychiatry 1999; 32: 136–41
   PubMed Web of Science ®Google Scholar
• Frye M A, Ketter T A, Kimbrell T A, et al. A placebo-controlled study oflamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol 2000; 20: 607–14
   PubMed Web of Science ®Google Scholar
• Erfurth A, Kammerer C, Grunze H, Normann C, Walden J. An open label study of gabapentin in the treatment of acute mania. J Psychiatr Res 1998; 32: 261–4
   Google Scholar
• Altshuler L L, Keck P E, Jr., McElroy S L, et al. Gabapentin in the acute treatment of refractory bipolar disorder. Bipolar Disord 1999; 1: 61–5
   PubMedGoogle Scholar
• Calabrese J R, Bowden C L, Sachs G S, Ascher J A, Monaghan E, Rudd G D. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J Clin Psychiatry 1999; 60: 79–88
   PubMed Web of Science ®Google Scholar
• Berk M. Lamotrigine and the treatment of mania in bipolar disorder. Eur Neuropsychopharmacol 1999; 9(Suppl 4)S119–23
   Google Scholar
• Obrocea G V, Dunn R M, Frye M A, et al. Clinical predictors of response to lamotrigine and gabapentin monotherapy in refractory affective disorders. Biol Psychiatry 2002; 51: 253–60
   PubMed Web of Science ®Google Scholar
• Bowden C L, Mitchell P, Suppes T. Lamotrigine in the treatment of bipolar depression. Eur Neuropsychopharmacol 1999; 9(Suppl 4)S113–7
   Google Scholar
• Fatemi S H, Rapport D J, Calabrese J R, Thuras P. Lamotrigine in rapid-cycling bipolar disorder. J Clin Psychiatry 1997; 58: 522–7
   PubMed Web of Science ®Google Scholar
• Kusumakar V, Yatham L N. An open study of lamotrigine in refractory bipolar depression. Psychiatry Res 1997; 72: 145–8
   PubMed Web of Science ®Google Scholar
• Ichim L, Berk M, Brook S. Lamotrigine compared with lithium in mania: a double-blind randomized controlled trial. Ann Clin Psychiatry 2000; 12: 5–10
   PubMedGoogle Scholar
• Calabrese J R, Suppes T, Bowden C L, et al. A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group. J Clin Psychiatry 2000; 61: 841–50
   PubMed Web of Science ®Google Scholar
• Wong I C, Mawer G E, Sander J W. Factors influencing the incidence of lamotrigine-related skin rash. Ann Pharmacother 1999; 33: 1037–42
   PubMedGoogle Scholar
• Applo G. Trileptal-Mania, bipolar and aggression disorders [written communication]. Novartis Pharmaceuticals Medical Information Department, East Hanover, NJ June 13, 2002
   Google Scholar
• Grant S M, Faulds D. Oxcarbazepine. A review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia and affective disorders. Drugs 1992; 43: 873–88
   PubMed Web of Science ®Google Scholar
• Emrich H M, Altmann H, Dose M, von Zerssen D. Therapeutic effects of GABA-ergic drugs in affective disorders. A preliminary report. Pharmacol Biochem Behav 1983; 19: 369–72
   PubMed Web of Science ®Google Scholar
• Teitelbaum M. Oxcarbazepine in bipolar disorder. J Am Acad Child Adolesc Psychiatry 2001; 40: 993–4
   PubMed Web of Science ®Google Scholar
• Grunze H, Erfurth A, Marcuse A, Amann B, Normann C, Walden J. Tiagabine appears not to be efficacious in the treatment of acute mania. J Clin Psychiatry 1999; 60: 759–62
   PubMed Web of Science ®Google Scholar
• Kaufman K R. Adjunctive tiagabine treatment of psychiatric disorders: three cases. Ann Clin Psychiatry 1998; 10: 181–4
   PubMedGoogle Scholar
• Schaffer L C, Schaffer C B. Tiagabine and the treatment of refractory bipolar disorder. Am J Psychiatry 1999; 156: 2014–5
   PubMed Web of Science ®Google Scholar
• Chengappa K N, Rathore D, Levine J, et al. Topiramate as add-on treatment for patients with bipolar mania. Bipolar Disord 1999; 1: 42–53
   PubMedGoogle Scholar
• Marcotte D. Use of topiramate, a new anti-epileptic as a mood stabilizer. J Affect Disord 1998; 50: 245–51
   PubMed Web of Science ®Google Scholar
• Calabrese J R, Keck P E, Jr., McElroy S L, Shelton M D. A pilot study of topiramate as monotherapy in the treatment of acute mania. J Clin Psychopharmacol 2001; 21: 340–2
   PubMed Web of Science ®Google Scholar
• McElroy S L, Suppes T, Keck P E, et al. Open-label adjunctive topiramate in the treatment of bipolar disorders. Biol Psychiatry 2000; 47: 1025–33
   PubMed Web of Science ®Google Scholar
• Tremont-Lukats I W, Megeff C, Backonja M M. Anticonvulsants for neuropathic pain syndromes: mechanisms of action and place in therapy. Drugs 2000; 60: 1029–52
   PubMed Web of Science ®Google Scholar
• Zakrzewska J M, Chaudhry Z, Nurmikko T J, Patton D W, Mullens E L. Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial. Pain 1997; 73: 223–30
   PubMed Web of Science ®Google Scholar
• Canavero S, Bonicalzi V. Lamotrigine control of trigeminal neuralgia: an expanded study. J Neurol 1997; 244: 527
   PubMed Web of Science ®Google Scholar
• Lunardi G, Leandri M, Albano C, et al. Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia. Neurology 1997; 48: 1714–7
   PubMed Web of Science ®Google Scholar
• Simpson D M, Olney R, McArthur J C, Khan A, Godbold J, Ebel-Frommer K. A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy. Neurology 2000; 54: 2115–9
   PubMed Web of Science ®Google Scholar
• McCleane G. 200 mg daily of lamotrigine has no analgesic effect in neuropathic pain: a randomized, double-blind, placebo controlled trial. Pain 1999; 83: 105–7
   PubMed Web of Science ®Google Scholar
• Solaro C, Messmer Uccelli M, Uccelli A, Leandri M, Mancardi G L. Low-dose gabapentin combined with either lamotrigine or carbamazepine can be useful therapies for trigeminal neuralgia in multiple sclerosis. Eur Neurol 2000; 44: 45–8
   PubMed Web of Science ®Google Scholar
• di Vadi P P, Hamann W. The use of lamotrigine in neuropathic pain. Anaesthesia 1998; 53: 808–9
   PubMed Web of Science ®Google Scholar
• Leandri M, Lundardi G, Inglese M, et al. Lamotrigine in trigeminal neuralgia secondary to multiple sclerosis. J Neurol 2000; 247: 556–8
   PubMed Web of Science ®Google Scholar
• Finnerup N B, Sindrup S H, Bach F W, Johannesen I L, Jensen T S. Lamotrigine in spinal cord injury pain: a randomized controlled trial. Pain 2002; 96: 375–83
   PubMed Web of Science ®Google Scholar
• Eisenberg E, Lurie Y, Braker C, Daoud D, Ishay A. Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study. Neurology 2001; 57: 505–9
   PubMed Web of Science ®Google Scholar
• Vestergaard K, Andersen G, Gottrup H, Kristensen B T, Jensen T S. Lamotrigine for central poststroke pain:a randomized controlled trial. Neurology 2001; 56: 184–90
   PubMed Web of Science ®Google Scholar
• Zakrzewska J M, Patsalos P N. Oxcarbazepine: a new drug in the management of intractable trigeminal neuralgia. J Neurol Neurosurg Psychiatry 1989; 52: 472–6
   PubMed Web of Science ®Google Scholar
• Farago F. Trigeminal neuralgia: its treatment with two new carbamazepine analogues. Eur Neurol 1987; 26: 73–83
   PubMed Web of Science ®Google Scholar
• Remillard G. Oxcarbazepine and intractable trigeminal neuralgia. Epilepsia 1994; 35: S28–29
   Web of Science ®Google Scholar
• Savk E, Bolukbasi O, Akyol A, Karaman G. Open pilot study on oxcarbazepine for the treatment of notalgia paresthetica. J Am Acad Dermatol 2001; 45: 630–2
   PubMed Web of Science ®Google Scholar
• Novak V, Kanard R, Kissel J T, Mendell J R. Treatment of painful sensory neuropathy with tiagabine: a pilot study. Clin Auton Res 2001; 11: 357–61
   Google Scholar
• Edwards K, Glantz M. J., Button J. Efficacy and safety of topiramate in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study (abstractS15.001). Neurology 2000; 54: A81
   Google Scholar
• Bajwa Z H, Sami N, Warfield C A, Wootton J. Topiramate relieves refractory intercostal neuralgia. Neurology 1999; 52: 1917
   PubMed Web of Science ®Google Scholar
• Gilron I, Booher S L, Rowan J S, Max M B. Topiramate in trigeminal neuralgia: a randomized, placebo-controlled multiple crossover pilot study. Clin Neuropharmacol 2001; 24: 109–12
   PubMed Web of Science ®Google Scholar
• Solaro C, Uccelli M M, Brichetto G, Gaspperini C, Mancardi G. Topiramate relieves idiopathic and symptomatic trigeminal neuralgia. J Pain Symptom Manage 2001; 21: 367–8
   PubMed Web of Science ®Google Scholar
• Zvartau-Hind M, Din M U, Gilani A, Lisak R P, Khan O A. Topiramate relieves refractory trigeminal neuralgia in MS patients. Neurology 2000; 55: 1587–8
   PubMed Web of Science ®Google Scholar
• Remillard G. Oxcarbazepine and intractable trigeminal neuralgia. Epilepsia 1994; 35: S28–29
   Web of Science ®Google Scholar